3.5 billion and is preparing for pivotal phase 3 trials for its lead products in the US and EU. Organization & culture: Novadip Biosciences employs 45 dedicated professionals, fostering a collaborative and innovative environment. Our teams are committed to advancing the standard of care in regenerative medicine, driven by scientific excellence and patient-focused values. Recent developments: Novadip recently received RMAT designation from the FDA for NVD-003, its regenerative treatment for congenital pseudarthrosis of the tibia. The company has also reported positive interim clinical data for NVDX3 in spine fusion and is preparing for phase 3 trials for NVD-003 in both the US and EU.", "areaServed": "Brabant Wallon", "knowsAbout": [ "Chief Financial Officer", "Clinical Research Scientist", "Regulatory Affairs Manager", "Quality Assurance Specialist", "Business Development Manager" ], "address": { "@type": "PostalAddress", "addressLocality": "Ottignies-Louvain-la-Neuve", "addressCountry": "Belgium", "postalCode": "1348", "streetAddress": "11 Rue Granbonpré" } }
Joobs

💡 50% of hires happen without a job posting·

logo

NOVADIP Biosciences S.A.

  • Mont-Saint-Guibert, BE
  • 51-200
    • Pharmaceutical/Biotech

Contacts

Contact us for any questions or assistance you may need.

Ottignies-Louvain-la-Neuve

Ottignies-Louvain-la-Neuve

Rue Granbonpré 11, 1348 Ottignies-Louvain-la-Neuve, Belgium

Related companies in Pharmaceutical/Biotech

WideTech

WideTech

Herstal

Blue Pimento

Blue Pimento

Ottignies-Louvain-la-Neuve

Artemys

Artemys

Hoeilaart

Aedifica NV/SA

Aedifica NV/SA

Bruxelles

Tekst

Tekst

Ghent

Granutools

Granutools

Awans